Bio-Rad Laboratories (BIO) Cash from Operations Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.99% |
| Dec 31, 2025 | -10.94% |
| Sep 30, 2025 | -2.28% |
| Jun 30, 2025 | 4.81% |
| Mar 31, 2025 | 15.64% |
| Dec 31, 2024 | -4.92% |
| Sep 30, 2024 | 10.39% |
| Jun 30, 2024 | -8.88% |
| Mar 31, 2024 | 10.22% |
| Dec 31, 2023 | -5.06% |
| Sep 30, 2023 | 9.43% |
| Jun 30, 2023 | 4.72% |
| Mar 31, 2023 | 19.45% |
| Dec 31, 2022 | 2.80% |
| Sep 30, 2022 | -17.34% |
| Jun 30, 2022 | -3.13% |
| Mar 31, 2022 | 23.72% |
| Dec 31, 2021 | 12.51% |
| Sep 30, 2021 | 34.88% |
| Jun 30, 2021 | 14.91% |
| Mar 31, 2021 | 76.76% |
| Dec 31, 2020 | 52.29% |
| Sep 30, 2020 | 10.52% |
| Jun 30, 2020 | 19.04% |
| Mar 31, 2020 | 16.36% |
| Dec 31, 2019 | 31.78% |
| Sep 30, 2019 | 1.94% |
| Jun 30, 2019 | 15.12% |
| Mar 31, 2019 | -8.13% |
| Dec 31, 2018 | 8.29% |
| Sep 30, 2018 | 2.58% |
| Jun 30, 2018 | 31.59% |
| Mar 31, 2018 | 10.93% |
| Dec 31, 2017 | -4.27% |
| Sep 30, 2017 | -16.78% |
| Jun 30, 2017 | -3.23% |
| Mar 31, 2017 | -29.16% |
| Dec 31, 2016 | 3.07% |
| Sep 30, 2016 | 0.17% |
| Jun 30, 2016 | -6.90% |
| Mar 31, 2016 | -18.90% |
| Dec 31, 2015 | -18.57% |
| Sep 30, 2015 | 4.24% |
| Jun 30, 2015 | 1.15% |
| Mar 31, 2015 | 5.75% |
| Dec 31, 2014 | -19.06% |
| Sep 30, 2014 | -1.44% |